Investing Profile
Scott Gottlieb
VCInvestor
Partner at New Enterprise Associates
nea.com/team/scott-gottlieb-m...Washington, District of Columbia
Your Intro Paths to Scott Gottlieb
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Scott is a member of
New Enterprise Associates (NEA) Network
106 CONNECTIONS
Pfizer Network
77 CONNECTIONS
Pfizer Network
77 CONNECTIONS
Wesleyan University Network
44 CONNECTIONS
New Enterprise Associates Network
20 CONNECTIONS
Find Scott Gottlieb on
cbCurrent Investing Position
New Enterprise Associates (NEA) Partner
Investment Range
$2.0M - $50.0M
Sweet Spot
$25.0M
Investments On Record
4
Current Fund Size
$6.2B
Scott Gottlieb is on these Sector & Stage Rankings
Scott Gottlieb's Investments On Record (3)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Xaira Therapeutics | Series AApr 2024$1B | $1B |
Comanche Biopharma | Series BJan 2024$75M SeedJan 2021 | $110M |
Resilience | Series BNov 2020$750M | $1B |
Scott Gottlieb's Experience
Member of the Board of Directors Pfizer2019 - Present
Elected Member National Academy of Medicine2018 - Present
Partner New Enterprise Associates2007 - Present
Senior Fellow American Enterprise Institute2003 - Present
Independent Member of the Board of Directors ICON plcPresent
Independent Member of the Board of Directors Gradalis, Inc.Present
Independent Member of the Board of Directors Daiichi Sankyo USPresent
Independent Member of the Board of Directors Sumitomo Pharma OncologyPresent
Commissioner United States Food and Drug AdministrationPresent
Independent Member of the Board of Directors PfizerPresent
Board Member Aetion, a Datavant CompanyPresent
Independent Member of the Board of Directors Tempus AIPresent
Chairman of the Board of Directors IlluminaPresent
Board Member ResiliencePresent
Board Member Comanche BiopharmaPresent
Board Member Xaira TherapeuticsPresent
Independent Member of the Board of Directors UnitedHealth GroupPresent
Partner New Enterprise Associates (NEA)Present
Commissioner FDA2017 - 2019
Member Federal Health IT Policy Committee U.S. Department of Health and Human Services (HHS)2013 - 2017
Member of the Policy Board Society of Hospital Medicine2011 - 2017
Independent Member of the Board of Directors Daiichi Sankyo, Inc.2015 - 2017
Independent Member of the Board of Directors American Pathology Partners2012 - 2017
Clinical Assistant Professor NYU Langone Health2011 - 2017
Member of the Product Investment Board GlaxoSmithKline2010 - 2017
Member of the Board of Directors Gradalis, Inc.2015 - 2017
Member of the Board of Directors MedAvante2007 - 2017
Member of the Board of Directors Tolero Pharmaceuticals, Inc.2015 - 2016
Member of the Board of Directors Aptiv Solutions2012 - 2014
Member of the Policy Board The Leukemia & Lymphoma Society2012 - 2014
Independent Member of the Board of Directors Bravo Health2009 - 2011
Independent Member of the Board of Directors Molecular Insight Pharmaceuticals2007 - 2010
Deputy Commissioner for Medical and Scientific Affairs FDA2005 - 2007
Senior Adviser to the Commissioner and Director of Medical Policy Development FDA2003 - 2004
Senior Adviser to the Administrator Centers for Medicare & Medicaid Services2004 - 2004
Medical Staff Writer British Medical Journal1998 - 2003
Investment Banking Analyst Alex Brown & Sons1994 - 1995
Scott Gottlieb's Education
Mount Sinai School of Medicine of New York University Resident Internal Medicine Residency Program
Mount Sinai School of Medicine of New York University Doctor of Medicine (MD) Medicine
Wesleyan University BA Economics
Icahn School of Medicine at Mount Sinai Doctor of Medicine (MD) Medicine
Icahn School of Medicine at Mount Sinai Resident Internal Medicine Residency Program
Investors who invest with Scott Gottlieb
Sign in with Google →Scouts & Angels Affiliated With Scott Gottlieb
Sign in with Google →